News

ZS’s India hub is reshaping global healthcare by pioneering AI and GenAI applications in drug discovery, clinical trials, and ...
That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...
Balancing the emerging benefits of AI in pharmacovigilance with new responsibilities and demands from regulators in enhancing ...
Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...
Therapy is a well-tested approach to helping people with mental health challenges, yet research shows that nearly 50% of ...
Health systems across the U.S. are accelerating partnerships with tech companies to embed AI into clinical care, operations and administrative workflows. In June, Rochester, Minn.-based Mayo Clinic ...
China has become the second country to launch clinical trials for invasive brain-computer interface (BCI) devices in humans.
PanOmiQâ„¢ Research sets a new global benchmark for precision health innovation.
Recursion Pharmaceuticals (NASDAQ: RXRX) is not the most famous artificial intelligence (AI) stock on the market, but the ...
In this Q&A, Megan Bailey, EVP and president of central laboratories and international, Labcorp, discusses how central labs ...
The Chicago-based physicians group refers to AI as augmented intelligence, not artificial, but whatever the name, the ...